MRK vs CVS
By Alex · Tickerpine
Merck & Company, Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CVS |
|---|---|---|
| Price | $132.92 | $94.72 |
| Market cap | $327.94B | $121.14B |
| P/E ratio | 106.3 | 24.7 |
| ROE | 6.96% | 6.21% |
| Profit margin | 4.77% | 1.18% |
| Revenue growth | 5.10% | 7.10% |
| Dividend yield | 2.56% | 2.84% |
| Beta | 0.21 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CVS in plain English
- MRK is the bigger company — about 2.7× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.7 vs 106.3).
- MRK earns a higher return on equity (7% vs 6%).
- CVS is growing revenue faster (7% vs 5%).
- CVS has the higher dividend yield (2.84% vs 2.56%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.